Volume 17, Number 4—April 2011
Nosocomial Pandemic (H1N1) 2009, United Kingdom, 2009–2010
|Patient no.||Age/sex||Duration, d
||Maximum level of care*||Outcome|
|Hospital admission to symptom onset||Symptom onset to receipt of antiviral therapy|
|16||12 y/F||10||Not given||3||Recovered|
|17||2 y/M||24||Not given||0/1||Died at home|
|20||123 d/F||123‡||Unknown data||3||Died after transfer to another hospital|
|23||9 y/M||Unknown (transferred)||3||3||Recovered|
|24||12 y/M||14||Not given||0/1||Recovered|
|26||64 d/M||64‡||Not given||1||Recovered|
*Level 3 care is given to patients requiring advanced respiratory support alone or basic respiratory support and support for >2 organ systems; this level includes all patients with complex conditions that required support for multiorgan failure (intensive care unit). Level 0 care is given to patients whose care needs can be met through normal ward care. Level 1 care is given to patients at risk for a deteriorating condition or recently relocated from higher levels of care whose needs can be met in an acute-care ward with additional advice and support from the critical-care team.
†Oseltamivir was replaced with zanamivir on day 11 because of identification of the H275Y drug-resistant mutation (patient also received acyclovir throughout hospitalization);
‡Inpatient since birth.
§Attributed to pandemic (H1N1) 2009.
- Page created: July 25, 2011
- Page last updated: July 25, 2011
- Page last reviewed: July 25, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)